RealPage Expected to Dip and 4 Stock Analyses to Eye

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

RealPage, Inc. (NASDAQ:RP) shares are expected by Barrington to see a 10 percent decrease today after the company’s mixed Q3 results, and the firm said that it would use the sell-off as a buying opportunity. The firm keeps an Outperform rating and a $30 price target on the stock.

BG Medicine, Inc. (NASDAQ:BGMD) price target has been reduced by Lazard Capital after CMS set Galectin-3 reimbursement at $18.34, which is far lower than the $48 the firm expected. The firm keeps its Buy rating the stock.

Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.

SAIC, Inc. (NYSE:SAI): VirnetX (AMEX:VHC) won a patent case against Apple (NASDAQ:AAPL), and Wells Fargo notes that SAIC  is entitled to 25 to 35 percent of any proceeds that VirnetX gains from the patents that were at issue in the case. The firm thinks that SAIC has the ability to gain $100 million or more from VirnetX if the verdict is upheld on appeal. The firm keeps its Underperform rating on the stock.

BorgWarner Inc. (NYSE:BWA) has been removed from Morgan Stanley’s Best Ideas List as a result of ongoing industry pressure in Europe. The firm keeps an Overweight rating on the stock.

CenturyLink, Inc. (NYSE:CTL) is believed by Wells Fargo to have reported solid Q3 results and to have provided strong Q4 guidance. According to the firm, the company’s revenue trends have shown improvement, and it keeps its Outperform rating on the stock.

Don’t Miss: Are CBS Shares a Buy After Earnings?


More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business